This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CERVIX_SQUAM_EXALLC for full statistics.
Squamous cell neoplasms and carcinoma of cervix
C3_CERVIX_SQUAM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
232 |
4. Check minimum number of eventsNone |
232 |
5. Include endpointsNone |
232 |
6. Filter based on genotype QC (FinnGen only) |
232 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Squamous cell neoplasms and carcinoma of cervix
based on the number of shared cases.
Similar with more cases:
- Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of cervix uteri
- Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 232 | 232 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 43.06 | 43.06 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 225
- Matched controls
- 2248
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
204.7
164
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
128.9
111
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
1650.9
107.6
96
*
128
Kela drug reimbursment
Cancers of female genital organs
91.4
64.9
70
11
ULA02
NOMESCO Finland
Kolposcopy
11.8
51.1
109
166
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
20.2
47.0
73
52
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
9.9
46.8
112
204
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
13.6
46.7
88
101
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.3
40.2
96
166
8070/3-C53.1
ICD-O-3
Squamous cell carcinoma, NOS, of exocervix
+∞
36.4
34
*
LCD30
NOMESCO Finland
Radical hysterectomy
406.9
36.0
35
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
43.9
30.4
37
10
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
29.8
28
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
74.1
28.8
32
5
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
165.4
28.3
29
*
WF002
NOMESCO Finland
Radical radiotherapy
20.0
26.5
40
24
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
66.1
25.7
29
5
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
15.9
25.5
42
32
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
79.3
25.4
28
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
73.0
23.4
26
*
8070/3-C53.0
ICD-O-3
Squamous cell carcinoma, NOS, of endocervix
+∞
23.3
22
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
19.8
22.6
34
20
ZXC96
NOMESCO Finland
Robot assisted procedure
22.8
21.0
30
15
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
230.2
20.9
21
*
B01AB10
ATC
tinzaparin; parenteral
9.3
20.5
44
57
LDA10
NOMESCO Finland
Curettage of cervix uteri
9.9
20.3
42
51
ZX080
NOMESCO Finland
Image guided radiotherapy
27.6
20.1
27
11
ZX095
NOMESCO Finland
Combined chemoradiotherapy
115.2
19.9
21
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
68.7
17.0
19
*
A04AA55
ATC
palonosetron, combinations; systemic
11.7
16.3
30
29
H02AB02
ATC
dexamethasone; systemic
5.6
15.9
49
106
C53.81
ICD-10 Finland
Overall squamous cell carcinoma of the cervix uteri
+∞
15.8
15
*
C53.10
ICD-10 Finland
Malignant tumor of the exocervix without histology
+∞
15.8
15
*
A04AA01
ATC
ondansetron; systemic, rectal
6.9
15.6
40
68
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
11.3
15.5
29
29
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
8.8
15.3
33
43
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
34.3
15.1
19
6
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
14.7
14
*
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
14.7
14
*
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
14.7
14
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.8
14.2
42
86
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
80.1
13.7
15
*
JN5JS
NOMESCO Finland
Extensive PET-MRI of body metabolism
+∞
13.7
13
*
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
13.7
13
*
C53.91
ICD-10 Finland
Squamous cell carcinoma in an unspecified location in the cervix
148.5
13.6
14
*
LEB00
NOMESCO Finland
Biopsy of vagina
15.1
13.6
22
16
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
24.3
13.1
18
8
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
12.8
78
312
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.8
12.7
60
197
1801A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Exocervix
+∞
12.6
12
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.8
12.4
114
596
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
28.5
12.2
16
6
JN4BD
NOMESCO Finland
Extensive body CT
4.9
11.8
40
95
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.7
11.7
27
39
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
68.6
11.7
13
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
11.5
11
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
11.5
11
*
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
11.5
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
8.8
11.4
24
30
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
29.7
10.9
14
5
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
+∞
10.5
10
*
LAG11
NOMESCO Finland
Laparoscopic oophoropexy
+∞
10.5
10
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
24.7
10.4
14
6
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
42.0
10.1
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
21.2
9.9
14
7
WW500
NOMESCO Finland
Blood transfusion
8.7
9.6
20
25
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.9
9.3
19
23
N02AA05
ATC
oxycodone; systemic
3.5
9.0
44
146
B01AB05
ATC
enoxaparin; parenteral
2.5
8.7
83
423
UKC02
NOMESCO Finland
Cystoscopy
3.8
8.4
36
107
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
8.4
8
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
8.2
87
465
Z51.5
ICD-10 Finland
Palliative care
5.4
8.2
24
49
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.0
8.1
19
29
ZX090
NOMESCO Finland
Other technic of radiotherapy
7.0
8.1
19
29
WZC30
NOMESCO Finland
Teaching
3.5
7.8
37
120
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
15.7
7.8
12
8
WF049
NOMESCO Finland
Radiotherapy of metastasis
15.7
7.8
12
8
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.7
7.8
12
8
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
46.6
7.8
9
*
A04AD12
ATC
aprepitant; systemic
8.1
7.5
16
21
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
82.6
7.5
8
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
20.8
7.2
10
5
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
7.4
7.1
16
23
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.4
6.9
12
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.1
6.7
20
42
L03AA02
ATC
filgrastim; parenteral
10.5
6.6
12
12
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
18.6
6.3
9
5
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
6.6
6.3
15
24
18011
ICD-8 Finland
NA
+∞
6.3
6
*
JN5KS
NOMESCO Finland
Very extensive PET-MRI of body metabolism
+∞
6.3
6
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.1
6.3
16
28
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
27.5
6.3
8
*
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
7.0
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
39
90
5.01
16.41
2.1
1.4
—
—
—
0
0
(4035726)
53
162
3.94
15.51
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
100
463
3.04
14.99
2.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
49
5.85
13.58
2.4
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
107
609
2.40
9.66
3.7
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
102
591
2.30
8.60
4.5
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
112
686
2.22
8.14
6.5
3.9
g/l
33.4
36.0
3.53
104
631
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
12
8.66
7.63
2.6
1.5
—
—
—
0
0
(4281824)
13
22
6.20
7.46
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
110
3.10
7.01
2.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
127
860
2.05
6.70
6.4
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
119
798
2.01
6.34
2.8
2.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
16
6.49
6.00
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
85
514
2.03
5.98
1.5
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
21
5.45
5.58
1.1
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
70
405
2.04
5.49
6.7
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
82
506
1.96
5.35
4.0
3.1
e6/l
81.2
61.5
0.17
67
380
(40768795) Lymph node Pathology biopsy report
10
20
5.18
4.82
1.1
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
39
188
2.29
4.81
1.9
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
87
568
1.85
4.67
3.8
2.0
—
—
—
0
0
(3026782) Osmolality of Urine
58
331
2.00
4.65
3.3
2.7
mosm/kgh2o
494.3
533.8
0.95
53
286
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
245
2.04
4.08
4.1
2.6
e6/l
5.4
3.6
0.30
28
117
(40758558) Short blood count panel - Blood
69
435
1.83
4.06
12.2
6.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
65
426
1.73
3.28
3.9
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
69
460
1.71
3.28
4.0
2.9
e6/l
0.6
0.5
0.25
57
339
(1761482) Bacteria [#/volume] in Urine by Culture
14
49
2.98
3.25
5.4
4.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
266
1.86
3.20
3.9
2.5
e6/l
1.6
1.1
0.35
27
139
(3012544) pH of Venous blood
28
140
2.14
3.16
7.0
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
86
614
1.64
3.13
5.5
7.6
inr
1.1
1.2
0.35
20
194
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
34
3.35
3.10
1.9
2.7
u/ml
0.4
0.4
—
5
25
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
45
3.00
3.08
1.8
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
8
7.66
3.07
1.8
1.6
ug/l
14.4
17.8
—
6
8
(3000850) Epithelial cells [#/volume] in Urine
55
353
1.73
2.97
2.7
2.7
e6/l
10.0
9.1
0.09
50
315
(3013826) Glucose [Moles/volume] in Serum or Plasma
126
997
1.58
2.93
5.2
4.0
mmol/l
6.6
6.5
0.26
120
906
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
112
866
1.57
2.86
8.8
5.5
mmol/l
1.2
1.2
1.39
91
733
(3018095) Leukocytes [#/volume] in Urine
85
618
1.59
2.82
5.0
3.6
e6/l
280.3
87.0
0.87
68
414
(3013650) Neutrophils [#/volume] in Blood by Automated count
129
1042
1.54
2.64
15.2
8.8
e9/l
4.1
4.0
0.32
121
914
(3021601) Nitrite [Presence] in Urine by Test strip
115
907
1.53
2.62
6.3
5.1
estimate
0.0
0.0
0.00
15
174
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
7
7.27
2.56
1.8
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
7
7.27
2.56
1.8
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
115
912
1.52
2.52
4.4
3.7
estimate
0.0
0.0
0.00
15
168
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
168
1.90
2.51
3.7
3.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
65
457
1.59
2.44
3.7
2.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
156
1753
0.66
2.16
3.7
4.0
mmol/l
4.9
4.8
0.52
151
1640
(3003458) Phosphate [Moles/volume] in Serum or Plasma
30
177
1.80
2.15
11.5
3.9
mmol/l
1.0
1.0
0.15
30
156
(3015736) pH of Urine
93
724
1.47
2.15
4.3
3.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
146
1242
1.47
2.12
6.9
4.6
e6/l
3094.0
3150.7
—
6
21
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
629
1.47
2.02
4.9
3.1
mmol/l
2.3
2.4
0.60
76
557
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
139
0.35
1.96
1.6
1.3
—
44.5
—
0
6
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
78
596
1.47
1.95
3.8
2.9
u/l
33.3
29.9
0.25
73
564
(40761535) Cells panel - Urine sediment
26
152
1.80
1.93
4.6
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
86
2.05
1.90
6.3
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
186
1678
1.55
1.89
21.0
11.4
ml/min/173m2
80.1
83.1
0.95
162
1348
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
13
59
2.27
1.88
2.1
1.6
ug/l
4.8
1.4
0.59
13
51
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
156
1738
0.69
1.87
3.7
4.0
mmol/l
1.5
1.6
0.99
150
1619
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
404
1.51
1.85
3.8
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
147
1280
1.41
1.70
6.5
4.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
105
1.88
1.69
12.8
6.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
33
483
0.63
1.67
2.1
1.6
mmol/l
1.7
1.4
1.50
25
411
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
14
3.63
1.62
2.0
3.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
157
0.43
1.62
3.1
2.3
—
20.4
—
0
6
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
163
1785
0.71
1.56
3.9
4.4
mmol/l
2.9
2.9
0.15
153
1655
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
86
1.92
1.54
2.1
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
15
3.38
1.53
1.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
151
1670
0.73
1.49
3.4
3.6
mmol/l
1.4
1.2
1.83
144
1548
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
38
2.42
1.47
1.6
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
179
0.48
1.47
1.3
1.8
nmol/l
381.7
371.6
—
9
163
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
88
1.88
1.45
1.6
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
16
3.17
1.44
2.4
3.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
22
135
1.70
1.42
6.0
6.3
%
93.3
96.1
0.68
22
130
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
94
780
1.34
1.38
6.6
5.0
mmol/l
1.2
1.2
1.25
89
713
(3008152) Bicarbonate [Moles/volume] in Arterial blood
16
91
1.81
1.32
7.1
6.3
mmol/l
25.3
24.7
0.34
16
86
(3049717) Cytology report of Urine Cyto stain
10
48
2.13
1.29
3.2
2.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
36
2.26
1.25
2.0
2.4
mmol/l
22.7
23.9
—
8
28
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
151
0.51
1.19
1.5
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
52
402
1.38
1.18
1.5
1.7
mg/l
1.5
0.9
0.69
43
307
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
33
0.00
1.17
0.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
103
1.70
1.16
2.5
2.1
u/l
194.6
4096.0
—
10
41
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
73
1.83
1.13
2.4
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
31
220
1.47
1.12
2.2
1.7
s
28.4
29.1
0.51
31
212
(3038515) Glucose [Moles/volume] in Venous blood
8
41
1.98
1.10
2.0
2.5
mmol/l
7.2
7.2
—
8
41
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
195
1833
1.40
1.08
22.9
12.5
mg/l
28.5
19.9
2.62
170
1405
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
75
1.78
1.05
3.8
3.3
%
47.3
46.3
0.04
13
75
(3007164) IgA [Mass/volume] in Serum or Plasma
29
396
0.69
1.04
1.6
1.4
g/l
2.5
2.1
0.59
19
243
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
47
1.95
1.03
2.0
2.8
mg/l
6.6
10.0
—
9
42
(3048689) Calprotectin [Mass/mass] in Stool
32
233
1.43
1.02
1.6
1.9
ug/g
73.1
108.6
0.66
25
179
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
68
1.81
1.02
1.9
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
49
1.87
1.00
2.4
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
33
244
1.41
0.98
2.5
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
51
407
1.32
0.95
4.3
3.6
kg/l
1.0
1.0
—
8
60
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
27
2.25
0.94
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
18
118
1.57
0.94
3.5
2.4
g/l
67.3
67.1
0.05
18
110
(3008898) HLA-B27 [Presence]
5
101
0.48
0.92
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
103
904
1.25
0.91
4.7
3.6
estimate
0.0
0.0
0.00
15
174
(3019060) Gas panel - Arterial blood
14
87
1.65
0.90
5.4
4.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
42
1.94
0.89
2.0
2.5
mmol/l
1.8
1.4
—
8
42
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
222
1.40
0.89
6.1
5.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
88
1.63
0.86
1.9
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
134
1217
1.24
0.85
3.1
3.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
31
1.96
0.85
1.0
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
22
155
1.46
0.85
8.4
5.8
kpa
10.6
12.2
1.06
22
148
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
22
155
1.46
0.85
8.4
5.8
kpa
5.1
5.1
0.08
22
148
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
32
1.90
0.82
1.7
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
16
106
1.55
0.81
4.6
3.2
e9/l
79.4
72.6
0.31
11
82
(3013512) EKG study
56
464
1.27
0.80
3.9
3.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
33
1.84
0.79
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
418
1.28
0.79
2.6
2.2
mg/l
3.5
3.0
0.61
42
362
(3021589) Normoblasts [#/volume] in Blood
89
780
1.23
0.78
10.2
8.6
e9/l
0.0
0.0
0.50
75
638
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
53
1.73
0.76
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
715
1.23
0.75
5.0
3.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
164
1738
0.81
0.74
4.4
4.1
mmol/l
6.0
5.8
1.13
153
1604
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
76
1.61
0.73
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
76
1.61
0.73
1.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
25
2.02
0.73
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.8
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
25
2.02
0.73
1.8
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.6
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
57
1.60
0.72
2.3
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
58
489
1.25
0.72
4.5
3.8
estimate
0.0
0.0
0.00
15
171
(42529406) Shigella sp [Presence] in Stool by Culture
12
77
1.59
0.70
1.4
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
42
1.69
0.69
1.1
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
27
1.87
0.69
2.0
3.1
%
2.9
1.6
—
5
21
(3018418) pH of Serum or Plasma
63
540
1.23
0.67
3.6
3.7
ph
7.4
7.4
0.18
12
100
(3047181) Lactate [Moles/volume] in Blood
7
43
1.65
0.67
7.0
6.4
mmol/l
1.7
1.1
—
7
38
(3001019) Free T4 and TSH panel - Serum or Plasma
8
127
0.62
0.66
2.5
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
29
1.74
0.64
1.8
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
100
902
1.19
0.63
3.1
2.9
ug/l
170.8
84.7
1.50
94
839
(3035285) Chloride [Moles/volume] in Venous blood
5
30
1.68
0.62
1.8
2.0
mmol/l
101.0
106.3
—
5
30
(3041354) Potassium [Moles/volume] in Venous blood
5
30
1.68
0.62
1.8
2.0
mmol/l
3.7
4.0
—
5
30
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
373
0.78
0.61
1.4
1.3
u/ml
19.5
7.9
0.42
12
146
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
53
1.53
0.59
2.1
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
35
1.73
0.58
1.2
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
59
1.55
0.55
9.8
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
119
1281
0.85
0.55
3.0
3.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
60
1.52
0.55
9.3
7.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
260
1.27
0.55
2.0
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
126
1.38
0.53
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
168
1755
0.85
0.50
4.5
5.2
mu/l
1.8
2.5
0.53
157
1634
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
342
0.79
0.50
2.0
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
45
1.57
0.49
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
21
164
1.31
0.48
9.5
3.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
520
1.18
0.47
4.5
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
68
1.49
0.47
1.3
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
242
0.77
0.47
1.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
192
1.28
0.47
1.4
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
8
116
0.68
0.47
1.6
1.9
g/l
0.9
1.5
—
8
105
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
49
1.44
0.46
1.6
2.4
%
149.6
181.5
—
7
49
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
70
628
1.16
0.46
3.0
3.6
ng/l
29.1
35.8
0.30
41
388
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
35
296
1.21
0.44
3.1
3.6
ng/l
598.2
134.3
0.51
25
198
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
213
1.25
0.43
1.8
1.5
—
—
—
0
0
(3020891) Body temperature
8
57
1.42
0.42
4.9
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
227
0.78
0.42
1.8
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
79
1.41
0.41
1.8
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
17
0.00
0.41
0.0
2.0
—
47.8
—
0
8
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
9.8
—
0.7
—
0
17
(1616796) Gas panel - Central venous blood
5
34
1.48
0.40
5.0
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
105
0.66
0.40
1.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
124
1.31
0.40
1.3
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
19
0.00
0.39
0.0
1.2
—
32.3
—
0
19
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.1
—
0
5
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
12
89
1.37
0.38
8.0
3.1
kpa
5.0
5.2
0.34
12
80
(21494755) Public health laboratory ask at order entry panel
14
180
0.76
0.38
1.4
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
196
1905
1.19
0.38
26.8
13.9
umol/l
75.1
68.9
1.31
196
1905
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
404
0.84
0.38
1.2
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
10
135
0.73
0.37
3.0
2.3
g/l
10.4
10.2
—
10
123
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
372
0.84
0.37
1.4
1.3
iu/ml
13.0
29.8
—
10
132
(3022621) pH of Urine by Test strip
15
117
1.30
0.36
2.6
2.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
43
1.41
0.35
1.2
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
154
1.25
0.35
3.8
3.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
44
1.37
0.34
1.0
1.5
g/l
37.4
37.6
—
6
44
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
20
164
1.24
0.34
3.5
4.1
u/l
223.5
236.3
0.23
20
158
(3012516) Albumin [Mass/volume] in Urine
47
421
1.15
0.32
2.9
3.0
mg/l
1623.5
218.9
0.46
29
251
(3022217) INR in Platelet poor plasma by Coagulation assay
24
203
1.20
0.31
15.2
18.7
inr
0.9
1.2
—
5
32
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
41
457
0.88
0.29
1.4
1.2
u/ml
0.5
2.3
1.20
14
133
(40768797) Stomach Pathology biopsy report
20
236
0.83
0.28
1.6
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
97
918
1.10
0.26
6.3
5.4
e9/l
1.6
2.0
2.65
90
828
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
142
1.21
0.25
2.1
2.8
ml/min/173m2
62.0
67.8
—
8
61
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
17
142
1.21
0.25
3.9
4.2
mmol/l
1.2
1.2
0.18
17
127
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
126
0.78
0.25
2.1
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
171
1.19
0.24
1.8
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
79
1.28
0.22
1.6
2.2
%
1.8
1.0
—
10
79
(3009542) Hematocrit [Volume Fraction] of Blood
173
1687
1.10
0.22
22.1
13.0
%
37.0
39.2
2.03
129
1271
(42870588) Differential panel, method unspecified - Blood
61
569
1.10
0.22
5.9
5.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
45
413
1.11
0.22
2.7
2.5
umol/l
318.9
5135.4
1.81
37
352
(3009508) Creatinine [Moles/volume] in Urine
50
462
1.10
0.21
2.5
2.8
mmol/l
6.5
7.0
0.45
37
379
(3050129) First trimester maternal screen panel - Serum or Plasma
8
104
0.76
0.21
1.5
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
11
0.00
0.21
0.0
4.6
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
0.9
—
0
10
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
2.0
—
0
10
(3011412) CD3 cells [#/volume] in Blood
0
12
0.00
0.21
0.0
2.0
—
1.1
—
0
5
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
48
443
1.11
0.21
4.0
3.7
mg/mmol
34.6
8.4
0.75
33
259
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
123
0.80
0.21
1.6
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
136
1.19
0.20
2.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
111
0.80
0.20
2.0
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
174
1.16
0.20
1.8
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
1.1
—
0
7
(4010399)
10
122
0.81
0.19
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
25
278
0.89
0.18
1.2
1.4
titre
380.0
530.1
—
6
67
(3021960) Folate [Moles/volume] in Serum or Plasma
36
391
0.91
0.17
1.6
1.5
nmol/l
16.5
22.0
2.24
31
332
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
215
0.87
0.17
1.3
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
82
1.23
0.17
9.3
4.2
mmol/l
24.9
24.9
—
10
82
(3000764) Benzodiazepines [Presence] in Urine
5
67
0.74
0.17
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
67
0.74
0.17
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
67
0.74
0.17
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
68
0.73
0.17
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
276
0.89
0.16
1.8
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
133
1366
0.94
0.16
4.0
4.0
mm/h
16.5
11.2
2.25
122
1256
(1002224) Polysomnography panel
6
79
0.75
0.16
1.0
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
9
78
1.16
0.15
2.9
2.5
u/l
41.3
39.8
—
9
72
(40768793) Breast Pathology biopsy report
9
80
1.13
0.15
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
147
1504
0.94
0.15
3.9
4.5
pmol/l
14.8
14.6
0.42
138
1382
(3002256) Pathology report gross observation
25
227
1.11
0.15
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
122
1.16
0.14
8.9
4.9
mmol/l
1.3
1.4
0.08
14
117
(3000492) Spirometry study
16
142
1.14
0.13
1.8
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
194
1916
1.08
0.12
13.8
9.5
u/l
25.8
23.2
0.70
194
1853
(40761511) CBC panel - Blood by Automated count
194
1917
1.07
0.11
19.2
11.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
92
893
1.05
0.11
6.5
5.3
e9/l
0.6
0.5
0.47
85
789
(3013115) Eosinophils [#/volume] in Blood
96
934
1.05
0.10
6.4
5.7
e9/l
0.2
0.2
0.76
88
838
(3006315) Basophils [#/volume] in Blood
92
895
1.05
0.10
6.5
5.4
e9/l
0.0
0.0
0.89
84
789
(40760892) CBC W Ordered Manual Differential panel - Blood
47
449
1.06
0.09
4.3
5.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
47
1.07
0.09
1.2
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
58
1.04
0.08
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
62
0.80
0.08
1.6
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
62
0.80
0.08
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
66
1.06
0.08
2.1
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
80
0.87
0.07
1.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
130
0.92
0.04
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
13
140
0.92
0.04
3.1
4.4
%
0.8
0.8
—
6
43
(1761868) Lipid panel - Serum or Plasma
67
657
1.03
0.04
2.7
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
190
1.06
0.04
1.4
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
200
0.95
0.04
1.5
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
12
129
0.93
0.03
10.2
2.9
ng/l
107.3
75.9
0.42
12
116
(46235355) HIV 1 and 2 tests - Meaningful Use set
38
391
0.97
0.03
2.1
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
12
128
0.93
0.02
3.2
4.6
%
0.0
0.1
—
5
38
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
121
1201
1.02
0.02
3.5
2.8
u/l
55.0
39.9
0.77
115
1131
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
247
0.97
0.01
1.8
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
166
0.96
0.00
1.6
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
151
0.99
0.00
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
33
325
1.02
0.00
1.6
1.7
nmol/l
938.7
1182.3
0.95
26
251
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
687
1.01
0.00
2.0
1.9
pmol/l
83.6
97.3
1.68
47
347
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
14.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
0.3
—
0
7
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
22.7
—
0
7
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
93.0
—
0
7
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
99
0.91
0.00
2.1
2.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.4
—
76.3
—
0
5
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
1640.0
—
0
5
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
29.4
—
0
9
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
55
0.91
0.00
1.8
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
9
0.00
0.00
0.0
1.9
—
11.0
—
0
9
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
75.2
—
0
6
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
78
0.89
0.00
1.1
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
234.8
—
0
5
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
-0.00
0.0
1.1
—
5.6
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CERVIX_SQUAM – Squamous cell neoplasms and carcinoma of cervix
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).